Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting Review

Industry Collaboration International Collaboration

cited authors

  • Reck, Martin; Garassino, Marina Chiara; Imbimbo, Martina; Shepherd, Frances A.; Socinski, Mark A.; Shih, Jin-Yuan; Tsao, Anne; Lee, Pablo; Winfree, Katherine B.; Sashegyi, Andreas; Cheng, Rebecca; Varea, Rocio; Levy, Benjamin; Garon, Edward

Publication Date

  • June 1, 2018

webpage

published in

category

keywords

  • Angiogenesis
  • Immunotherapy
  • Nintedanib
  • Non-small-cell lung cancer
  • Ramucirumab

start page

  • 62

end page

  • 69

volume

  • 120